Article
In silico characterization of MC4R variants reveals insights into Setmelanotide pharmacogenomics and personalized medicine for obesity.
Personalized medicine - 1 Jun 2026
Nunes Bruno Fonseca, de Souza Grinevicius Valdelúcia Maria Alves, Pedroza Rozangela Curi, Filippin-Monteiro Fabíola Branco
Abstract excerpt
AIMS: The Melanocortin-4 receptor is a key regulator of energy homeostasis, and loss-of-function variants are the most common cause of monogenic obesity. This study aimed to characterize MC4R genetic variants and evaluate their potential impact on receptor function and interaction with Setmelanotide. MATERIALS AND METHODS: An in silico approach was applied to analyze MC4R single nucleotide polymorphisms (SNPs)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
